Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Gottlieb Q&A: Confirmation Is Nearing, Will Complete Response Letters Finally Get Released?

Executive Summary

Gottlieb favors making the letters detailing application problems public, but industry still may oppose it; Senate schedules cloture vote for confirmation.

Advertisement

Related Content

Gottlieb Advances, But FDA's Future Seems Increasingly Partisan
Gottlieb Promotes 'Bottom-Up' Review To Increase FDA Efficiency, Consistency
Gottlieb's Confirmation: Will Industry Ties Remain A Big Deal After The Hearing?
REMS Reform Seems Distant Goal For Generics After Limited Support At US House Hearing
What Goes Up … US FDA Expects 2016 NME Approval Total To Come Down
REMS Abuse Legislation: GPhA and PhRMA Set To Battle Again
Oral History Of Drug Development: FDA’s Califf Wants Woodcock, Temple To Share Their Stories
FDA Orphan Approval Flexibility Remains Steady As Pressure Increases
FDA Talking To Industry About Releasing “Complete Response” Letters
“Emerging Sponsors” Pose Regulatory, Public Relations Challenges For Drug Review Process, FDA’s Jenkins Says

Topics

Advertisement
UsernamePublicRestriction

Register

PS120580

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel